0MSD.LSE

CompuGroup Medical AG O.N.

0MSD.LSE, UK

CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical care centers, and physician networks. This segment also offers solutions that cover all essential clinical, administrative, and billing functions, as well as internet and intranet solutions for the secure exchange of doctor and patient information; and data-driven products, software interfaces for information exchange, medical decision support tools, pharmaceutical and therapy databases, solutions for the insurance industry, and digital applications and mobile apps. Its Hospital Information Systems segment offers clinical and administrative solutions for the inpatient healthcare sector, including the facilitation of patient administration, resource and personnel management, medical-care documentation, billing, and financial and medical controlling; and clinical applications to support specialist departments, medical laboratories and radiology networks. This segment serves acute care hospitals, rehabilitation centers, welfare institutions, hospital networks, medical laboratories, and radiologists. The Pharmacy Information Systems segment provides administrative and billing-related software applications for pharmacies, which supports aspects of the supply chain for medication from procuring and shipping the medication, managing and controlling inventory, through to planning, and performing and monitoring retail activities. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

https://www.cgm.com

Stock Price

€0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
0MSD.LSE
stock
0MSD.LSE

Big pharma firms have paused nearly £2bn in UK investments this year | Pharmaceuticals industry The Guardian

Read more →
0MSD.LSE
stock
0MSD.LSE

Financial Markets Infrastructure and Data | LSEG LSEG

Read more →

Finn Analysis

(Last Updated 2025-03-31)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

0.29

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Medium

1.99

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.68 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.54 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

27.35 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

2.10

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.00% of the total shares of CompuGroup Medical AG O.N.

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

0

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-03-31)

Deep Value
Potential Value Candidate(6)
Defensive
Moderately Defensive(5.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.8)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(6)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(4)
Value
Undervalued(6.5)

Income Statement

(Last Updated 2025-03-31)

Revenue

€ 0

Cost Of Revenue

€ 0

Gross Profit

€ 0

Operating Expenses

€ 0

Operating Income

€ 0

Interest Expense

€ 0

Pretax Income

€ 0

Net Income

€ 0

Income Tax Expense

€ 0

EBITDA

€ 0

Total Other Income Expense Net

€ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-03-31)

Cash

€ 0

Short Term Investments

€ 0

Receivables

€ 0

Inventories

€ 0

Total Current Assets

€ 0

Property Plant Equipment

€ 0

Total Assets

€ 0

Payables

€ 0

Short Term Debt

€ 0

Long Term Debt

€ 0

Total Liabilities

€ 0

Equity

€ 0

Trend

Cash Flow

(Last Updated 2025-03-31)

Net Income

€ 0

Depreciation

€ 0

Change In Working Capital

€ 0

Cash From Operations

€ 0

Capital Expenditures

€ 0

Cash From Investing

€ 0

Cash From Financing

€ 0

Net Change In Cash

€ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.